Side benefit of statin drug includes lower infection rates

Some people must be asking themselves: Is there nothing statins can't do? New research suggests that atorvastin (Lipitor) is not only successful at reducing the risk of coronary heart disease and heart attacks, but also reduces the risk of acquiring a potentially fatal infectious disease.

Researchers 'stunned' to find approved cholesterol drug has negligible effect

The National Institutes of Health announced it is ending its study of the cholesterol drug Niaspan 18 months early. Tracking results showed the medication had almost no chance of being beneficial to patients, researchers found.